Last edition
News about "WuXi XDC"
WuXi XDC Grants Exclusive Global License for WuXiTecan-2 Platform in USD 885 Million Pact
WuXi XDC Cayman Inc., a global CRDMO specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has entered into a strategic collaboration with Earendil Labs to advance next-generation ADC development.
WuXi XDC | 03/03/2026 | By Darshana | 131
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members